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ORIGINAL ARTICLE
Community-based management and outcome of omphalitis in
newborns in Karachi, Pakistan
Farah Naz Qamar, Shiyam Sundar Tikmani, Fatima Mir, Anita Kazmi Mehdi Zaidi

Abstract
Objectives: To describe the clinical profile and outcome in newborns with omphalitis managed with home or clinicbased therapy.
Methods: The descriptive study was conducted from September 2004 to August 2007 in three low-income
communities in Karachi, Pakistan. Newborns with omphalitis detected by community health workers through active
surveillance were referred to local clinics. Those with physician-confirmed omphalitis were treated for 7 days with
topical gentian violet or oral cephalexin (as monotherapy) or topical gentian violet and oral cephalexin
(combination therapy) at physician discretion, or injectable therapy (procaine penicillin and gentamicin) if clinical
signs of sepsis were also present and family refused hospital referral. Follow-up was at 48-72 hours and 7 days. SPSS
16 was used for statistical analysis.
Results: Among 1083 newborns with omphalitis, 578 (53.4%) had peri-umbilical cellulitis without purulent
discharge; 365 (33.7%) had purulent discharge (with or without cellulitis); and 140 (13%) had omphalitis with sepsis.
Review of outcome data at one week showed that among 943 newborns without signs of sepsis, 938 (99.5%) had
improved; 2 (0.2%) died, and 2 (0.2%) were lost to follow-up. There were 5 (3.6%) therapy failures, among 140
newborns with omphalitis and sepsis managed with parenteral antibiotics at 48 hours, but 139 (99.2%) had
improved by one week, while 1 (0.8%) died.
Conclusion: In resource-constrained environments, omphalitis can be managed in the community with minimal
need for hospital referral. Further research to define optimal therapeutic regimens is needed.
Keywords: Omphalitis, Umbilical infection, Neonatal sepsis, Community case-management, Newborn, Pakistan.
(JPMA 63: 1364; 2013)

Introduction
Umbilical infections are an important cause of neonatal
morbidity and mortality in developing countries with
incidence rates as high as 55-197 per 1000 live births in
community-based studies.1 Home-births are a recognised
risk factor, associated with a 6-fold higher incidence rate
compared to hospital-born babies.2,3 A number of factors
contribute to the high incidence of omphalitis in
developing countries: unhygienic delivery practices,
unskilled birth attendants, use of non-sterile cutting
instruments, and harmful traditional cord care practices.3
An association between omphalitis and sepsis is
suggested by the fact that as many as one-fifth of
newborns admitted for sepsis also have omphalitis.3 The
significance of the association can be gauged by the fact
that application of 4% chlorhexidine to the umbilical
stump within 24 hours of birth in rural Nepal resulted in a
34% decline in all-cause neonatal mortality.4
The clinical presentation of omphalitis is variable and
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depends on the severity of infection. It may range from
purulent discharge, to erythema and swelling of varying
degrees, warmth, tenderness, and/or foul odour from
the site of the infection.5 Differentiating pus from
serous discharge and erythema from temporary redness
due to pressure requires skilled assessment. If
diagnosed early, omphalitis may successfully be
diagnosed in the community with the help of predefined,validated sign-based algorithms.4 The World
Health Organisation's (WHO) current recommendation
of inpatient management of omphalitis with parenteral
antibiotics is likely the result of paucity of data on
etiology and clinical effectiveness of oral and topical
agents in community-based settings.6 Adherence to this
recommendation is not only unfeasible due to financial
constraints, but also culturally unacceptable to many
families in South Asia in the first week of life. 7
Management of neonatal infections with simple home
or clinic-based regimens is, therefore, increasingly
being studied as an alternative approach to improve
patient compliance and clinical outcomes in resourcelimited environments with high neonatal mortality
rates.7,8 Efforts to identify and implement affordable
and effective community-based interventions for
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omphalitis may reduce the large burden of infectionrelated neonatal mortality in developing countries.
The objective of this study was to review outcome data on
the clinical effectiveness of simple regimens (topical
gentian violet, oral cephalexin, combination therapy with
topical gentian violet and oral cephalexin) used for the
treatment of omphalitis in primary care settings in three
low-income communities in Karachi, Pakistan, where
hospital referral was not feasible.

Patients and Methods
The descriptive study was conducted from September
2004 to August 2007 in three low-income (one urban and
two peri urban coastal) settlements of Karachi,
approximately 20-30 kilometers from the city centre. Each
settlement's primary healthcare needs are served by a
Department of Paediatrics and Child Health-run Primary
Health Centre (PHC) staffed by 2 physicians, a lady health
visitor (LHV) and community health workers (CHWs).
These PHCs were established for research studies on
common childhood diseases, but also function as the
main locus of care for families residing in the area because
healthcare for children under 5 years of age is provided
free of charge.
All study sites have an established neonatal surveillance
system run by the Department of Paediatrics and Child
Health, Aga Khan University, Karachi, in which local CHWs
visit each newborn 7-8 times in the first two months of
life, and refer sick newborns to the PHC. Neonatal
mortality rates in the three sites are in the range of 30-45
per 1000 live births. Seventy per cent of the deliveries are
conducted at home by traditional (unskilled) birth
attendants (TBAs) who have no formal certification or
licensure. The use of sterile delivery kits (as an indicator of
effective infection control practices) in home deliveries is
low (32%).9,10
The data for this study was derived from parent studies
approved by the Ethical Review Committee of the
University.11 These studies evaluated the ability of
paramedical staff to detect clinical signs of serious illness
in young infants, and evaluated clinic-based injectable
therapeutic options for young infants with clinical signs of
possible serious bacterial infection in situations where
referral failed. Neonates with omphalitis, from this 3-year
cohort study, who refused injectable antibiotics, were
observed with simple home-based treatment options and
data as collected.
CHWs were trained in identifying serious illnesses in
newborns in need of referral. Specific training
regarding omphalitis was given at each field site by a
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research supervisor who explained the signs and
symptoms of umbilical infection and showed
coloured photographs of its varying presentations.
The CHWs regularly followed up the birth cohort at
each of the three field sites. Using purposive sampling
neonates with omphalitis identified during the field
visits, were referred to the PHC, where the physician
confirmed the diagnosis, as well as recorded
presenting symptoms.
Omphalitis was categorised as peri-umbilical cellulitis
without purulent discharge; peri-umbilical cellulitis with
purulent discharge; or purulent discharge with minimal or
no cellulitis. The size of peri-umbilical cellulitis, if present,
was also recorded. Newborns with concurrent signs of
sepsis were categorised as having omphalitis with sepsis.
The diagnosis of sepsis was made on the basis of clinical
signs (Annexure).
Cases of omphalitis without sepsis were diagnosed and
treated with either topical gentian violet or oral
cephalexin or both, depending upon physician's
judgment from among the available therapies at the local
PHC. Oral cephalexin was given in a dose of 50 mg/kg/day
divided three times a day for 7 days, to be administered by
the mother/caretaker at home. Gentian violet's first
Annexure: Clinical Definition of Sepsis.
Any three of the following:
1. RR>60/min
2. Feeding difficulty/poor suck
3. Fever > 37.5 C (ax)
4. Temperature < 36.0 C (ax) and not increasing on warming
5. Lethargic or < normal movement
6. Excessive crying or irritability
7. Weak, abnormal or absent cry
8. Persistent vomiting (last 3 feeds)
9. abdominal distension
10. Hypoglycaemia - blood glucose < 40 mg/dl
11. Presence of skin, eye, or local umbilical infection
12. For babies < 7 days old: Presence of any maternal risk factor (premature
delivery, fever in the 24 hours prior to delivery, foul-smelling amniotic fluid,
prolonged labor of >12 hours, prolonged rupture of membranes > 12 hours)
or
Presence of any one of the following:
1. Apnea/poor respiratory efforts?(in >24 hours baby present on examination)
2. Seizures in last 24 hours
3. Bulging fontanelle
4. Temp > 38.5 C (ax)
5. Temp < 35.5 C (ax)
6. Severe lethargy/floppy baby
7. Capillary refill >2 secs after adequate warming
8. severe chest indrawing in >24 hour baby
9. grunting in >24 hour baby.
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application was done in the clinic and the mother was
given a bottle with gentian violet solution for home
application twice a day for 7 days. Those with treatment
failure were given clinic-based injectable procaine
penicillin and gentamicin if hospital referral was declined
by the family.

signs of sepsis; no improvement at 48 hours, or
development of clinical signs of sepsis (lethargy, poor
feeding, fever, hypothermia etc) or increase in
redness/cellulitis/discharge, or death.

Newborns with omphalitis and clinical signs of sepsis on
presentation whose families refused hospital referral
despite provision of free transport and cost of
medications were treated with procaine penicillin and
gentamicin, given once daily by intramuscular (IM)
injection at the clinic as well as topical gentian violet.
Injectable therapy for 7 days.

Results

Follow up evaluations was conducted at 48-72 hours,
and 7 days after enrollment in the study by physicians at
the clinics. The continued presence or resolution of
clinical signs or development of new clinical signs was
recorded in structured case report forms of the parent
studies on newborn illness. Families were advised
referral if at any time signs of sepsis or therapy failure
were observed. CHWs facilitated newborn visits if the
family did not bring the baby to the clinic for the
scheduled follow-ups.11

Omphalitis without purulent discharge was observed
in 578 (53.4%), omphalitis with purulent discharge in
365 (33.7%) and omphalitis with sepsis in 140 (13%)
(Table-1).

Main outcome measures, evaluated at 48 hours, and at 7
days after the initiation of treatment, included
decreasing area of redness/cellulitis or decrease in
purulent discharge, or complete resolution of clinical

High rates of success (>98%) with home-based therapy
were observed, regardless of the severity of omphalitis or
regimen used. Among newborns with omphalitis and
signs of sepsis on presentation, 5/140 (3.6%) failed

Data was analysed using SPSS 16.0.
Omphalitis was diagnosed by physicians in 1,083 babies
during the study period. Excluding newborns with
minimal peri-umbilical cellulitis and no purulent
discharge or signs of sepsis, the incidence of omphalitis
was estimated to be 110 per 1000 live births (95% CI:
102.3-118).

After 7 days of therapy, 1078 (99.5%) newborns were
successfully treated. There were 3 (0.3%) deaths and 2
(0.18%) were lost to follow-up. Of the 943 newborns with
omphalitis without clinical signs of sepsis, by 48 hours,
938 (99.5%) had clinically improved; and 5 (0.5%) failed
therapy, including 1 (0.1%) death.

Table: Clinical features, therapeutic regimens and outcomes of omphalitis.
Categories of Omphalitis

Omphalitis without purulent discharge
Cellulitis <2cm

n= 1083 (%)

Treatment regimen

No. receiving regimen

578 (53.4 %)
324 (56)

Gentian violet

158

Cephalexin

166

Improved 165 (99.4)

Outcome n (%)
Day 2

Day 7

Improved 155 (98.1)

Cured 158 (100.0)

Treatment failure 3 (1.9)
Cured 165 (99.4)
Died 1 (0.6)
Cellulitis >2cm
Swelling around umbilicus
Omphalitis with purulent discharge
No cellulitis or cellulitis <2cm with purulent discharge
Cellulitis of >2cm with purulent discharge
Swelling around umbilicus with purulent discharge
Omphalitis with sepsis

196 (34)
58 (10)
365 (33.7%)
125 (34)
198(54)
42 (11.5)
140 (13%)

Cephalexin
Cephalexin

Improved 196 (100)
Improved 58 (100)

Gentian violet and cephalexin,

123¹

Gentian violet and cephalexin
Gentian violet and cephalexin
Procaine penicillin + gentamicin
daily I/M + topical gentian violet5

196²
403
135

According to clinical judgment of treating physicians:
1Two newborns received oral cephalexin only and were improved.
2,3Four newborns received oral cephalexin and IM gentamicin and outcome was improved.
4One newborn in each of these groups was lost to follow up.
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Cured 195 (99.5)4
Cured 58 (100)
Improved 124 (99.2)
Cured 124 (99.2)
Treatment failure 1 (0.8)
Died 1 (0.8)
Improved 198 (100)
Cured 197 (99.5)4
Improved 42 (100)
Cured 42 (100)
Improved 135 (96.4)
Cured 139 (99.3)
Treatment failure 5 (3.6)
Died 1 (0.7)
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therapy at 48 hours and required alternative treatment or
hospital admission. Among these 140, newborns families
of 56 (40%) consented for a blood culture. Two (3.6%)
yielded pathogens (S. aureus and one polymicrobial
specimen
Klebsiellapneumoniae,
E.coli,
and
Enterobacterspp). Umbilical cultures were obtained from
54 (38%) of the 140 babies; 22 (40.74%) cultures were
negative, 19 (35%) yielded pure isolates, and 13 (24%)
were polymicrobial. Further details of etiological spectra
and antimicrobial resistance patterns have been reported
elsewhere.3
Among the 3 newborns that died, 1 (33.3%) death was
observed in a male newborn with minimal cellulitis
and no purulent discharge; 1 (33.3%) had purulent
discharge present at diagnosis, and 1 (33.3%) was also
diagnosed with sepsis at presentation. In 2 (66.6%) of
the three fatal cases, the neonates had clearly failed
therapy by 48 hours. Families were strongly
counselled about the need for hospital care, but they
chose not to accept referral or further clinic-based
injectable therapy. Both these neonates were female.
The third neonate who was diagnosed with mild
omphalitis refused to come for followup at the clinic.
Verbal audit at a later date suggested the cause of
death as sepsis.

Discussion
The high burden and lack of feasibility of delivering
parenteral therapy for neonatal infections in resourceconstrained settings has led to a pressing need to
explore alternative, easier-to-administer therapeutic
options for neonatal infections in community (home or
clinic-based) settings. Recent trials of home or clinicbased antibiotic treatment for neonatal infections in
areas of high neonatal mortality where hospital referral
was not feasible have shown significant reduction in
neonatal mortality when antibiotic therapy has been
delivered at home or PHCs located close to home.12,13
The antibiotics that have been successfully used for
community-based treatment of neonatal infections
(sepsis and pneumonia) include oral cotrimaxazole,
penicillin or cephalexin, usually in combination with IM
aminoglycosides.12,14 Although many trials have been
conducted for determining the best cord care practices
for prevention of omphalitis, but there are limited data
on effective management of omphalitis. 4,15 Some
clinicians have reported treating infants with minimal
symptoms with topical applications such as alcohol,
bacitracin or mupiricin.16 Others have treated cases of
omphalitis due to community-acquired methicillinresistant S. aureus with initially intravenous nafcillin
followed by topical gentamicin or mupirocin. Cases of
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omphalitis that occurred during a trial for triple dye vs.
dry cord care, by Janssen et al in British Colombia, were
treatedwith topical antibiotics (polysporin).17 However,
there are limited efficacy data on this practice or the use
of oral or topical antibiotics in umbilical infections, and
newborns with omphalitis almost always receive
hospital care and parenteral antibiotic therapy in
industrialised countries.
In developing countries, admission to hospitals and
parenteral antibiotics are not possible in most cases
due to social, cultural or economic reasons or in many
cases due to lack of access to healthcare facilities. A
system of early identification, simple home-based
treatment options coupled with close monitoring
may lead to improved outcomes and be costeffective. 12,18
In our study, cases of omphalitis were diagnosed and
treated on an outpatient basis and an excellent cure rate
was observed in all treatment groups (gentian violet, oral
cephalexin, a combination of gentian violet and oral
cephalexin, or injectable procaine penicillin and
gentamicin).
Topical gentian violet has been reported to have good
anti bacterial activity in vitro against S. aureus and also
against selected gram negative organisms such as
Pseudomonas.19 It has long been used in artificial media
to suppress growth of gram-positive organisms.20
It has been used to treat mild to moderate omphalitis in
India with close follow-up by CHWs. However, outcomes
have not been reported.18 Some supportive evidence
comes from the decrease in colonisation of the
umbilical cord by gram-positive organisms with the use
of triple dye (a combination of brilliant green,
proflavinehemisulphate, and gentian violet) for cord
care.17 The preparation is also considered useful for
topical use for skin infections due to S.aureus in primary
healthcare settings. It is a low-cost, safe and stable
compound, making it ideal for a public health formulary
list.19 As our experience has shown, topical application
of gentian violet appeared to be an effective and
inexpensive means of treatment of omphalitis in
community setting. However, neonates with only
minimal evidence of cellulitis without any purulent
discharge received gentian violet alone; therefore it is
difficult to comment on the efficacy of gentian violet as
stand-alone therapy for more severe forms of
omphalitis. The most common barrier to gentian violet
use is that it stains skin and clothing. Rarely, contact
sensitisation has also been reported.20
J Pak Med Assoc
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The use of oral antibiotics for neonatal infections in
community settings, where referral is not possible, has
been suggested by several authors in an effort to
improve neonatal survival in areas with high neonatal
mortality.7,9 Cephalexin is a well-tolerated, inexpensive,
first-generation cephalosporin with good activity against
gram-positive organisms such as Streptococcus
pyogenes and methicillin sensitive S. aureus. It is also
active against some enteric gram-negative rods.21 In
addition to cephalexin, there is also some evidence of
successful treatment of non-serious neonatal infections
caused by S. aureus (pustulosis and abscess) with oral
clindamycin and amoxicillin/clavulanate.22 We chose
cephalexin as the oral antibiotic of choice for the
management of omphalitis at home, instead of a purely
gram-positive agent such as cloxacillin because
information from microbial cultures revealed that
although S. aureus and streptococci were dominant
pathogens in our setting, polymicrobial infections,
including gram-negative rods, were also common,3 and
because of cost considerations and the ease of
availability of cephalexin in Pakistan. Parenteral
antibiotics followed by oral cephalexin has been used
successfully for a case of omphalitis occurring during a
preventive trial for cord care practices.23

the management of omphalitis.

Conclusion
The study corroborated prior reports of success in
improving neonatal clinical outcomes through early
recognition and effective community-based case
management in areas with high burden of neonatal
deaths. Further research is needed to define the most
effective therapeutic option for omphalitis as well as
duration in community settings.
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ERRATA
In the original article "Hepatitis B vaccination coverage in medical students at a
medical college of Mirpurkhas" which appeared on pages 680-682 of the July 2011
issue, the name of second author was misspelled.
His name should have appeared as Waseem Raja.
------------xxxxx-----------In the original article "Oral Clefts: A review of the cases and our experience at a single
institution" which appeared on pages 1098-1102 of the September 2013 issue, the
name of the second author was misspelled.
Her name should have appeared as Alina Ghani.
The Journal regrets these errors.
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